Rapid identification of different Escherichia coli ST131 clades. Matsumura Y, Pitout JDD, Peirano G, DeVinney R, Noguchi T, Yamamoto M, Gomi R, Matsuda T, Nakano S, Nagao M, Tanaka M, Ichiyama S. Antimicrob Agents Chemother. 2017;61: e00179-17. doi: 10.1128/AAC.00179-17.
Genomic epidemiology of global VIM-producing Enterobacteriaceae. Matsumura Y, Peirano G, Devinney R, Bradford PA, Motyl MR, Adams MD, Chen L, Kreiswirth B, Pitout JDD. J Antimicrob Chemother. 2017;72:2249-2258. doi: 10.1093/jac/dkx148.
Global Molecular Epidemiology of IMP-Producing Enterobacteriaceae. Matsumura Y, Peirano G, Motyl MR, Adams MD, Chen L, Kreiswirth B, DeVinney R, Pitout JD. Antimicrob Agents Chemother. 2017;61:e02729-16. doi: 10.1128/AAC.02729-16.
Population structure of Japanese extraintestinal pathogenic Escherichia coli and its relationship with antimicrobial resistance. Matsumura Y, Noguchi T, Tanaka M, Kanahashi T, Yamamoto M, Nagao M, Takakura S, Ichiyama S. J Antimicrobial Chemother. 2017;72:1040-1049.
Septic Arthritis due to Streptococcus dysgalactiae subspecies equisimilis in a Healthy School Child. Nakano S, Matsuoka N, Yamamoto M, et al. Pediatr Infect Dis J. 2017 Jun;36(6):621-622.
Clinical and microbiologic characteristics of cefotaxime-non-susceptible Enterobacteriaceae bacteremia: a case control study. Noguchi T, Matsumura Y, Yamamoto M, Nagao M, Takakura S, Ichiyama S. BMC Infect Dis. 2017 Jan 7;17(1):44.
Complete adherence to evidence-based quality-of-care indicators for Staphylococcus aureus bacteremia resulted in better prognosis. Nagao M, Yamamoto M, Matsumura Y, Yokota I, Takakura S, Teramukai S, Ichiyama S. Infection 2017 Feb;45(1):83-91.
Longitudinal Analysis of the Intestinal Microbiota in Liver Transplantation. Kato K, Nagao M, Miyamoto K, Oka K, Takahashi M, Yamamoto M, Matsumura Y, Kaido T, Uemoto S, Ichiyama S. Transplant Direct. 2017 Mar 10;3(4):e144.
血液分野
C/EBPβ is required for survival of Ly6C- monocytes. Tamura A, Hirai H, Yokota A et al. Blood 130(16):1809-1818, 2017.
Constitutively active ABL family kinases, TEL/ABL and TEL/ARG, harbor distinct leukemogenic activities in vivo. Yokota A, Hirai H, Shoji T et al. Leukemia 31(12):2742-2751, 2017
生理学分野
MicroRNA-33 Controls Adaptive Fibrotic Response in the Remodeling Heart by Preserving Lipid Raft Cholesterol. Nishiga M, Horie T, Kuwabara Y, Nagao K, Baba O, Nakao T, Nishino T, Hakuno D, Nakashima Y, Nishi H, Nakazeki F, Ide Y, Koyama S, Kimura M, Hanada R, Nakamura T, Inada T, Hasegawa K, Conway SJ, Kita T, Kimura T, Ono K. Circulation Research 2017 Mar 3;120(5):835-847.